How much has Hexagon Bio raised?

Hexagon Bio has raised $109M across 2 sourced rounds on record. The latest is $62M (Series B+), announced October 23, 2026.

Who invested in Hexagon Bio?

Investors on record for Hexagon Bio: 8VC, bpd partners, LeFrak, The Column Group and Two Sigma Ventures. The Column Group led a round.

Hexagon Bio

Health and bio

Latest funding

$62M Series B+ · October 23, 2026

Source: manilatimes.net

Total raised: $109M across 2 sourced rounds

All 3 rounds ↓

Website: hexagonbio.com.

LinkedIn: hexagon-bio.

Category: Health and bio.

Stage: Series B+.

Total raised: $109M in 2 sourced rounds.

Last round: Oct 23, 2026 · 0 days ago.

On Recent Funding since: Oct 23, 2026.

About Hexagon Bio

Recent Funding lists Hexagon Bio under Health and bio. It raised $62M in a Series B+ round in October 2026, according to manilatimes.net. Recent Funding has 2 sourced rounds on record for it, totaling $109M, the first in September 2020. Investors on record include 8VC, bpd partners, LeFrak, The Column Group and 1 other.

TIMELINE · MONEY RAISED

Hexagon Bio | 3279 days on the record

Raised $109M in 2 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

October 23, 2026
Series B+ · $62M
Source: manilatimes.net
September 15, 2020
Series A · $47M
TThe Column Group (lead), 88VC, LLeFrak, TTwo Sigma Ventures
Source: goo.gl
October 31, 2017
Seed · amount undisclosed
88VC (lead), Bbpd partners
Source: genengnews.com

Investors

Similar Health and bio companies

HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
OOxbridge Health$45M Series B+ · Oct 2026

Other companies backed by The Column Group

TTriGemX Bio$94M · Oct 2026
NNura Bio$73.8M Series B+ · Jun 2026
AAtavistik Bio$40M Series B+ · Mar 2026
AA2 Biotherapeutics$80M Series B+ · Jan 2025
AAccent Therapeutics$75M Series B+ · Jan 2024
SSynthekine$100M Series B+ · Jan 2023

The Column Group portfolio →

Questions and sources

Hexagon Bio: questions and answers

How much has Hexagon Bio raised?: Hexagon Bio has raised $109M across 2 sourced rounds on record. The latest is $62M (Series B+), announced October 23, 2026.
Who invested in Hexagon Bio?: Investors on record for Hexagon Bio: 8VC, bpd partners, LeFrak, The Column Group and Two Sigma Ventures. The Column Group led a round.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/hexagon-bio (get a free API key).